Griffith Statement on House Passage of SUPPORT Act

The U.S. House of Representatives passed H.R. 2483, the SUPPORT for Patients & Communities Reauthorization Act of 2025. This legislation helps continue important health programs that fight substance use disorder and promote recovery resources.

Following House passage of the bill, U.S. Congressman Morgan Griffith (R-VA) issued the following statement:

“We are seeing real progress in terms of treatment opportunities as well as recovery resources for those affected by substance use disorder. I am proud to support reauthorization of the SUPPORT Act, further strengthening our ability to combat the opioid crisis in Appalachia and giving Americans hope to rebuild their lives.”

BACKGROUND

Given the opioid epidemic hitting Appalachia, and Virginia’s Ninth District bordering the states of West Virginia, Kentucky, Tennessee and North Carolina, Congressman Griffith introduced during the last Congress the RECONNECTIONS Act of 2023.

Language from Congressman Griffith’s bill is now Section 103 of the SUPPORT for Patients & Communities Reauthorization Act of 2025. This section reauthorizes the prescription drug monitoring program, which is an important tool to track where prescription drugs are being dispensed at.

Congressman Griffith’s recent remarks in the Rules Committee on the SUPPORT for Patients & Communities Reauthorization Act of 2025 can be found here.

SUPPORT for Patients & Communities Reauthorization Act of 2025 now goes to the U.S. Senate for consideration.

Congressman Griffith is the House sponsor of the HALT Fentanyl Act. The HALT Fentanyl Act passedthe House in February of 2025.

###

Stay Connected

Use the form below to sign up for my newsletter and get the latest news and updates directly to your inbox.

Office Locations